Stay updated with breaking news from Exscientia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exscientia (NASDAQ:EXAI – Get Rating) is scheduled to be announcing its earnings results before the market opens on Wednesday, May 24th. Exscientia (NASDAQ:EXAI – Get Rating) last posted its earnings results on Thursday, March 23rd. The company reported ($0.38) EPS for the quarter. The business had revenue of $8.20 million during the quarter, compared to […]
Exscientia (NASDAQ:EXAI – Get Rating) and Palisade Bio (NASDAQ:PALI – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Earnings & Valuation This table compares Exscientia and Palisade Bio’s […]
Exscientia plc (NASDAQ:EXAI – Get Rating) was up 8.8% during mid-day trading on Monday . The stock traded as high as $5.77 and last traded at $5.69. Approximately 110,254 shares were traded during trading, a decline of 63% from the average daily volume of 302,019 shares. The stock had previously closed at $5.23. Wall Street […]
Changing the world through exceptional science and technology Professor Andrew Hopkins DPhil LLD FRSE, founder and Chief Executive of Exscientia plc (Nasdaq: EXAI), has been elected a Fellow of the
- Renowned thought leader in computational biology and data science for cancer research - - Over 180 publications on the evolutionary dynamics of cancer initiation, progression, response to therapy